Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical

J B Kuks1, H J Oosterhuis, P C Limburg

  • 1Department of Neurology, University Hospital Groningen, The Netherlands.

Journal of Autoimmunity
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

Methods in molecular biology (Clifton, N.J.)·2018
Same author

Identification of Lifelines participants at high risk for development of rheumatoid arthritis.

Annals of the rheumatic diseases·2017
Same author

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Clinical and experimental immunology·2017
Same author

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.

Annals of the rheumatic diseases·2017
Same author

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

Clinical and experimental immunology·2014
Same author

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

Lupus·2013

Thymectomy improved myasthenia gravis symptoms and reduced acetylcholine receptor antibodies (a-AChR). This effect was clearer in patients not taking immunosuppressants, showing a steady decrease in a-AChR and clinical improvement post-surgery.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Myasthenia gravis is an autoimmune disorder characterized by antibodies against acetylcholine receptors.
  • Thymectomy is a surgical option for myasthenia gravis, but its long-term effects on antibody levels require further investigation.

Purpose of the Study:

  • To evaluate the clinical course and serum antibody levels to acetylcholine receptors (a-AChR) in myasthenia gravis patients after thymectomy.
  • To assess the influence of thymectomy, total IgG levels, and immunosuppressive medication on a-AChR levels over time.

Main Methods:

  • Longitudinal follow-up of 82 myasthenia gravis patients for 1-8 years post-thymectomy.
  • Monitoring of serum a-AChR antibody levels and clinical status.
  • Analysis of the impact of total IgG and immunosuppressive drug use on a-AChR levels.

Related Experiment Videos

Main Results:

  • Serum a-AChR levels decreased after thymectomy, influenced by total IgG changes.
  • Immunosuppressive medication significantly affected serum a-AChR levels throughout the study period.
  • In a subgroup of 41 patients without thymoma and not on immunosuppressants, a steady decrease in a-AChR correlated with clinical improvement starting 6 weeks post-thymectomy.

Conclusions:

  • Thymectomy can lead to a reduction in a-AChR antibodies and clinical improvement in myasthenia gravis patients.
  • The impact of immunosuppressive medication on a-AChR levels should be considered when assessing treatment outcomes.
  • Discontinuation of immunosuppressants in select patients post-thymectomy may reveal a clearer correlation between reduced a-AChR and clinical recovery.